These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29407539)

  • 21. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
    Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
    J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.
    Ostacher MJ; Iosifescu DV; Hay A; Blumenthal SR; Sklar P; Perlis RH
    Bipolar Disord; 2014 Mar; 16(2):199-203. PubMed ID: 24372835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study.
    Bares M; Novak T; Brunovsky M; Kopecek M; Stopkova P; Krajca V; Höschl C
    J Psychiatr Res; 2012 Feb; 46(2):219-25. PubMed ID: 21937059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ziprasidone monotherapy in bipolar II depression: an open trial.
    Liebowitz MR; Salmán E; Mech A; Dunner D; Johnson AE; Akhtar J; Pratap R
    J Affect Disord; 2009 Nov; 118(1-3):205-8. PubMed ID: 19264363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Hsu J; Sarma K; Sachs G
    Am J Psychiatry; 2014 Feb; 171(2):160-8. PubMed ID: 24170180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.
    Tohen M; McDonnell DP; Case M; Kanba S; Ha K; Fang YR; Katagiri H; Gomez JC
    Br J Psychiatry; 2012 Nov; 201(5):376-82. PubMed ID: 22918966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S; Chiu YY; Hsu J; Cucchiaro J; Loebel A
    Clin Ther; 2016 Jan; 38(1):4-15. PubMed ID: 26730454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studies.
    Tohen M; Katagiri H; Fujikoshi S; Kanba S
    J Affect Disord; 2013 Jul; 149(1-3):196-201. PubMed ID: 23485111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divalproex extended-release in acute bipolar II depression.
    Wang PW; Nowakowska C; Chandler RA; Hill SJ; Nam JY; Culver JL; Keller KL; Ketter TA
    J Affect Disord; 2010 Jul; 124(1-2):170-3. PubMed ID: 19923006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
    Husain MI; Chaudhry IB; Husain N; Khoso AB; Rahman RR; Hamirani MM; Hodsoll J; Qurashi I; Deakin JF; Young AH
    J Psychopharmacol; 2017 Sep; 31(9):1166-1175. PubMed ID: 28857658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder.
    Lapidus KA; Gabbay V; Mao X; Johnson A; Murrough JW; Mathew SJ; Shungu DC
    Neurosci Lett; 2014 May; 569():74-9. PubMed ID: 24704328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
    Berk M; Dean O; Cotton SM; Gama CS; Kapczinski F; Fernandes BS; Kohlmann K; Jeavons S; Hewitt K; Allwang C; Cobb H; Bush AI; Schapkaitz I; Dodd S; Malhi GS
    J Affect Disord; 2011 Dec; 135(1-3):389-94. PubMed ID: 21719110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal proton magnetic resonance spectroscopy study investigating oxidative stress as a result of alcohol and tobacco use in youth with bipolar disorder.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    J Affect Disord; 2015 Apr; 175():481-7. PubMed ID: 25679204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.